Tags |
|
|
Links |
|
|
Top Articles - Alfred E. Neuman, Stock Guru
This past week there has been a huge break in the stock market. Almost without exception the talking heads on CNBC-TV, radio and all b
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
rokerage companies have been copying Alfred E. Neuman, “What, me worry?”
The Dow Jones Industrial Average has plunged more than 500 p
The Dow Jones Industrial Average has plunged more than 500 p
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
oints and now investors are becoming nervous. They are starting to think about selling. Wall Street never wants anyone to take money a
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ay from them.
One of the very big shots of the largest brokerage house said this is a good time to buy. He has a reputation of being
One of the very big shots of the largest brokerage house said this is a good time to buy. He has a reputation of being
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
very secret about his investment strategy. If this is such a good place to buy why is he telling the little guy? That’s the one whose
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ocket he is usually picking.
There is not a single brokerage house that I have ever heard of that teaches brokers to protect clients’
There is not a single brokerage house that I have ever heard of that teaches brokers to protect clients’
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
money. How? Very simple. With stop loss orders. Brokers are discouraged from these types of orders.
For the past 3 years the market
For the past 3 years the market
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
as been advancing and many investors have been recovering from the 2000-2003 losses and many new positions have accumulated good profi
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ts. Has any broker called his customer to encourage him to place an open stop loss to lock in those profits? The base answer is NO in
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
apital letters.
Investment specialists such as brokers and financial planners have no clue as to how to do this. Most brokers ask oth
Investment specialists such as brokers and financial planners have no clue as to how to do this. Most brokers ask oth
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
er brokers what do to do. And the other brokers don’t know. Customers listen to the Wall Street line “you are in for the long haul” an
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
d “the market always comes back”. These are misdirections (lies) to keep them from selling.
Ask any investors who were fully invested
Ask any investors who were fully invested
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
in January 2000 and see if they have recovered to their original January 2000 amount not counting additions, of course.
Professional
Professional
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
traders will always say you must keep losses small and let profits run. Small losses are your friend. Always know how much is at risk
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
efore the trade is initiated. Buying a $40 stock means not more than a $4/share risk. The upside will take care of itself with a follo
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
wing stop order.
People don’t like to take a loss. They want to wait for it to come back to even. “Even” is a loser because it is rar
People don’t like to take a loss. They want to wait for it to come back to even. “Even” is a loser because it is rar
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
lf it comes back. It you bite into something that tastes bad you spit it out immediately. If you keep chewing on it and swallow it ma
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
y kill you. That is the difference in a small loss and a big one that will kill an investment account.
An investor should pick up the
An investor should pick up the
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
phone to ask his broker what is the exit strategy to protect his account if this is the start of the next bear market. Listen carefull
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
y for non-answers.
Alfred E. Nueman says, "What, me worry? I have my stop loss orders permanently in place. I sleep well every night”
Alfred E. Nueman says, "What, me worry? I have my stop loss orders permanently in place. I sleep well every night”
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/102002/toparticles-Alfred-E-Neuman-Stock-Guru.html">Alfred E. Neuman, Stock Guru</a>
BB link (for phorums):
[url=http://www.toparticles.org.ua/article/102002/toparticles-Alfred-E-Neuman-Stock-Guru.html]Alfred E. Neuman, Stock Guru[/url]
Related Articles:
Uncertainty - The Doorway To Possibilities
Career Advice: You Can't Get There If You Don't Know Where You Are Going
Transforming Problems into Sales
Bookmark it:
|